Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery
Conditions
- Metastatic Colon Carcinoma
- Metastatic Colorectal Carcinoma
- Metastatic Rectal Carcinoma
- RAS Family Gene Mutation
- Stage III Colon Cancer AJCC v7
- Stage III Colorectal Cancer AJCC v7
- Stage III Rectal Cancer AJCC v7
- Stage IIIA Colon Cancer AJCC v7
- Stage IIIA Colorectal Cancer AJCC v7
- Stage IIIA Rectal Cancer AJCC v7
- Stage IIIB Colon Cancer AJCC v7
- Stage IIIB Colorectal Cancer AJCC v7
- Stage IIIB Rectal Cancer AJCC v7
- Stage IIIC Colon Cancer AJCC v7
- Stage IIIC Colorectal Cancer AJCC v7
- Stage IIIC Rectal Cancer AJCC v7
- Stage IV Colon Cancer AJCC v7
- Stage IV Colorectal Cancer AJCC v7
- Stage IV Rectal Cancer AJCC v7
- Stage IVA Colon Cancer AJCC v7
- Stage IVA Colorectal Cancer AJCC v7
- Stage IVA Rectal Cancer AJCC v7
- Stage IVB Colon Cancer AJCC v7
- Stage IVB Colorectal Cancer AJCC v7
- Stage IVB Rectal Cancer AJCC v7
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Trametinib
- DRUG: Trifluridine and Tipiracil Hydrochloride
Sponsor
City of Hope Medical Center
Collaborators